Last updated 17 days ago
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
428 patients around the world
Available in Chile, United States
Amgen
2Research sites
428Patients around the world
This study is for people with
Asthma
Requirements for the patient
To 75 Years
All Gender
Medical requirements
SponsorAmgen
Conditions
Requirements
To 75 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06376045
